International Common Disease Alliance (ICDA) aims to improve prevention, diagnosis, and treatment of common diseases by accelerating discovery from genetic maps to biological mechanisms to physiology and medicine, to benefit people around the world.

Save the date! The next ICDA Scientific Plenary will be held virtually on March 8-9, 2022.

ICDA PRS Task Force published it's perspective piece, "Responsible use of polygenic risk scores in the clinic: potential benefits, risks, and gaps."

Read the article at Nature Medicine.

International Common Disease Alliance (ICDA)